Condition 1: Rheumatoid arthritis. Condition 2: Rheumatoid arthritis. Rheumatoid arthritis, unspecified Rheumatoid arthritis, unspecified
Conditions
Interventions
Prescribing 80 mg of asprin on the patient's group and taking the drug for one week.After the last dose and re sampling, blood samples will be used to measure serum TX levels.
Treatment - Drugs
Prescribing 80 mg of asprin on the patient's group and taking the drug for one week.After the last dose and re sampling, blood samples will be used to measure serum TX levels
Sponsors
Connective Tissue research Center- Tabriz University of Medical Sciences
abriz University of Medical Sciences, Tabriz, Iran
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with rheumatoid arthritis who have been diagnosed with EULAR 2010 ACR criteria and have been ill for 6 months Exclusion criteria: Includes recent use of aspirin and anti-coagulant drugs, history of aspirin allergy, renal failure (creatinine above 8.1 mg / dL), thrombotic cytopenia, pregnancy, gastric ulcer and gastrointestinal bleeding. Patients with maternal and metabolic disorders are also among the exclusion criteria.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation. Timepoint: One week. Method of measurement: Elisa. | — |
Secondary
| Measure | Time frame |
|---|---|
| TXA2. Timepoint: one weak. Method of measurement: Elisa.;TX-A2. Timepoint: One week. Method of measurement: Elisa. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir ghorbanihaghjo
Tabriz University of Medical Sciences
Outcome results
None listed